Correction to: VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

Correction to: VEGF₁₆₅b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

Oncogene. 2023 Aug;42(32):2471-2472. doi: 10.1038/s41388-023-02764-w.

Asma Boudria^{1

2}, Cherine Abou Faycal^#^{1

2}, Tao Jia^#^{1

2}, Stephanie Gout^{1

2}, Michelle Keramidas^{2

3}, Chloé Didier^{2

3}, Nicolas Lemaître^{2

4}, Sandra Manet^{2

5}, Jean-Luc Coll^{2

3}, Anne-Claire Toffart^{2

4}, Denis Moro-Sibilot^{2

4}, Corinne Albiges-Rizo^{2

5}, Véronique Josserand^{2

3}, Eva Faurobert^{2

5}, Christian Brambilla^{2

4}, Elisabeth Brambilla^{2

4}, Sylvie Gazzeri^{1

2}, Beatrice Eymin^{6

7}

¹ INSERM U1209, UMR CNRS 5309, Team RNA splicing, Cell Signaling and Response to Therapies, Grenoble, 38042, France.
² Université Grenoble Alpes, Institut Pour l'Avancée des Biosciences, Grenoble, 38041, France.
³ INSERM, U1209, UMR CNRS 5309, Team Cancer Targets and Experimental Therapeutics, Grenoble, 38042, France.
⁴ INSERM U1209, UMR CNRS 5309, Team Tumor Molecular Pathology and Biomarkers, Grenoble, 38042, France.
⁵ INSERM U1209, UMR CNRS 5309, Team Cell Adhesion Dynamics and Differentiation, Grenoble, 38042, France.
⁶ INSERM U1209, UMR CNRS 5309, Team RNA splicing, Cell Signaling and Response to Therapies, Grenoble, 38042, France. Beatrice.Eymin@ujf-grenoble.fr.
⁷ Université Grenoble Alpes, Institut Pour l'Avancée des Biosciences, Grenoble, 38041, France. Beatrice.Eymin@ujf-grenoble.fr.

^# Contributed equally.

No abstract available